VGLL4 interrupts YAP/TEAD4 complex in liver cancer (Feng et al., 2020) and TEAD/TCF4 (Transcription Factor 4) complex to suppress Wnt/β-catenin downstream targets (Jiao et al., 2017). This evidence concerns the gene TCF4 and liver cancer.